FDA could authorize vaccine for young kids soon after Oct. 26 meeting, vaccine chief says
The Food and Drug Administration could issue an emergency use authorization of the Pfizer vaccine for children ages 5 to 11 soon after Oct. 26, when the agency's advisory committee plans to discuss Pfizer's data, the FDA's vaccine chief said Tuesday.
Dr. Peter Marks couldn't give an exact day, but said the FDA has "a track record of trying to move relatively swiftly" after these committee meetings and feels the weight of the world -- and then some -- to get this done.
"When we did the adult approval, we felt the weight of the world," Marks told ABC News during the Q&A portion of a town hall hosted by the COVID-19 Vaccine Education and Equity Project. "Here, we feel like the weight of the world, plus the weight of Mars on top of us, or some other planet as well."
"This is clearly one of the most important issues to get done so we're not going to be wasting any time," he added.
Marks said he's confident that the FDA will would have all necessary data from Pfizer in time for the meeting.
Last month, Pfizer said data shows its vaccine is safe and effective for children ages 5 to 11.
-ABC News' Cheyenne Haslett